Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
50 participants
OBSERVATIONAL
2025-03-25
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators have just established an expert group, comprising researchers, healthcare professionals, and PD organisations (including persons with PD) and reached consensus on essential priority clinical therapy research questions on PA and methodological considerations. The next phase entails performing a multicentre feasibility/pilot study, further developing and refining the assessment battery and research questions linked to the improved explanatory model for PA and methodology, to inform the definite larger clinical cohort study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of an Active Lifestyle Promotion Program for Patients With Parkinson's Disease
NCT00748488
Support for Physical Activity in Everyday Life With Parkinson's Disease
NCT05510739
Exercise Study For People With Parkinson's Disease
NCT00387218
The Effects of 24-Weeks Community-based Brisk Walking in People With Parkinson's Disease
NCT06707402
Feasibility of Motor-cognitive Home Training for Parkinson's Disease Using eHealth Technology
NCT05027620
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
People with Parkinson's disease
No intervention
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mild to severe disease severity ( Hoehn \& Yahr 1-4).
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lund University
OTHER
Göteborg University
OTHER
Umeå University
OTHER
Region Stockholm
OTHER_GOV
Vastra Gotaland Region
OTHER_GOV
Region Skane
OTHER
Region Västerbotten
OTHER_GOV
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Erika Franzén
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erika Franzén
Role: PRINCIPAL_INVESTIGATOR
Karolinska Institutet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Karolinska institutet
Stockholm, Solna, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-06332
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2024-07526-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.